XOMA Royalty Corporation (XOMAP)

Market Cap	278.98M
Revenue (ttm)	28.49M
Net Income (ttm)	-19.29M
Shares Out	11.98M
EPS (ttm)	-1.65
PE Ratio	n/a
Forward PE	n/a
Dividend	$2.16 (8.38%)
Ex-Dividend Date	Apr 3, 2025

Volume	4,099
Open	26.08
Previous Close	26.03
Day's Range	25.73 - 26.08
52-Week Range	24.85 - 26.51
Beta	1.00
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2025

About XOMAP

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 13
• Stock Exchange: NASDAQ
• Ticker Symbol: XOMAP
• Website: https://www.xoma.com

Financial Performance

In 2024, XOMA Royalty's revenue was $28.49 million, an increase of 498.72% compared to the previous year's $4.76 million. Losses were -$19.29 million, -58.33% less than in 2023.